Skip to search boxSkip to navigationSkip to main content

Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort

  • TEDDY study group
    ,
  • Ashok Sharma
    ,
  • ,
  • David Hadley
    ,
  • William Hagopian
    ,
  • Edwin Liu
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Objectives There are significant geographical differences in the prevalence and incidence of celiac disease that cannot be explained by HLA alone. More than 40 loci outside of the HLA region have been associated with celiac disease. We investigated the roles of these non-HLA genes in the development of tissue transglutaminase autoantibodies (tTGA) and celiac disease in a large international prospective cohort study. Methods A total of 424,788 newborns from the US and European general populations and first-degree relatives with type 1 diabetes were screened for specific HLA genotypes. Of these, 21,589 carried 1 of the 9 HLA genotypes associated with increased risk for type 1 diabetes and celiac disease; we followed 8676 of the children in a 15 y prospective follow-up study. Genotype analyses were performed on 6010 children using the Illumina ImmunoChip. Levels of tTGA were measured in serum samples using radio-ligand binding assays; diagnoses of celiac disease were made based on persistent detection of tTGA and biopsy analysis. Data were analyzed using Cox proportional hazards analyses. Results We found 54 single-nucleotide polymorphisms (SNPs) in 5 genes associated with celiac disease (TAGAP, IL18R1, RGS21, PLEK, and CCR9) in time to celiac disease analyses (10−4>P>5.8x10−6). The hazard ratios (HR) for the SNPs with the smallest P values in each region were 1.59, 1.45, 2.23, 2.64, and 1.40, respectively. Outside of regions previously associated with celiac disease, we identified 10 SNPs in 8 regions that could also be associated with the disease (P<10−4). A SNP near PKIA (rs117128341, P = 6.5x10−8, HR = 2.8) and a SNP near PFKFB3 (rs117139146, P<2.8x10−7, HR = 4.9) reached the genome-wide association threshold in subjects from Sweden. Analyses of time to detection of tTGA identified 29 SNPs in 2 regions previously associated with celiac disease (CTLA4, P = 1.3x10−6, HR = 0.76 and LPP, P = 2.8x10−5, HR = .80) and 6 SNPs in 5 regions not previously associated with celiac disease (P<10−4); non-HLA genes are therefore involved in development of tTGA. Conclusions In conclusion, using a genetic analysis of a large international cohort of children, we associated celiac disease development with 5 non-HLA regions previously associated with the disease and 8 regions not previously associated with celiac disease. We identified 5 regions associated with development of tTGA. Two loci associated with celiac disease progression reached a genome-wide association threshold in subjects from Sweden.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

e0152476

Journal (Volume, Issue Number)

PloS one (Volume 11, Issue 3)

Publication milestones

  • Published - 03/2016

Publication status

Published - 03/2016

ISSN

1932-6203

Publication IDs

  • Scopus: 84983038866
  • PubMed: 27015091
  • ORCID: /0000-0001-9597-4374/work/54990705

Publication metrics

Metrics

Scopus
citations
SciVal
citations
23
SciVal
FWCI
1.19
SciVal
Author count
18
SciVal
Paper percentile
88
Fractional count
2
Fractional count
0.11
Fractional count
16
Fractional count
0.89
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Social media
76
Captures
121
Citation count
54

Funding Details

None of the authors listed has any financial or other conflicts to disclose relevant to this article. This study was funded by DK 63829, 63861, 63821, 63865, 63863, 63836, 63790 and UC4DK095300 and contract no. HHSN267200700014C from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS), Juvenile Diabetes Research Foundation (JDRF), and Centers for Disease Control and Prevention (CDC). The complete TEDDY Study Group is listed in the Supplementary material.
FundersFunding number
CDC
-
NIAID
-
NIDDK
U01DK063790
NIEHS
-
NICHD
-
JDRF
-